Biotechnology News

November 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ: RGEN) today reported financial results for its third quarter and year-to-date period ended September 30, 2012. The Company reported net income for the three-month period ended...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus reports financial results for the third quarter ended September 30, 2012.

November 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Corporate Update at Credit Suisse 2012 Healthcare Conference in Phoenix on November 15th

November 8, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2012 Global Healthcare Conference on Thursday November 15, 2012 at...

November 8, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation today announced financial results for the third quarter and nine months ended September 30, 2012.

November 8, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) today reported financial results for the three- and nine-month periods ended September 30, 2012. Highlights of the third quarter include: Total net revenues increased...

November 8, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it has reached an agreement with Glaxo Group Limited (GSK) to terminate their collaboration agreement concerning Horizant® (gabapentin enacarbil) Extended-...

November 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 15, 2012 at the Jefferies 2012 Global Healthcare Conference in London, UK. The GTx presentation will begin at 11...

November 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today provided a Company update and reported financial results for the third quarter of 2012. “We expect to complete enrollment this quarter in our two pivotal Phase III clinical trials...

November 8, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the third quarter and nine months ended September 30, 2012. “Despite the recent setbacks, we are focused on...

November 8, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica's service revenues increased by 15.7% in the 3Q'12 and its non-GAAP operating income increased 26.1%, as demand for its products increased along with its operating leverage.

November 8, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-U.S. and Non-U.K. Media Boehringer Ingelheim and Eli Lilly and Company are pleased to announce that the recruitment of patients for CAROLINA (Cardiovascular Outcome Study of Linagliptin versus...

November 8, 2012

LOS ANGELES--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only 8 November, 2012--Pivotal data from the RELY-ABLE® study have provided additional data to support the long-term safety profile and efficacy of Pradaxa® (dabigatran...

November 8, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG): New results from re-evaluation of two separate and previously performed clinical trials show that DiaGenic’s technology has the potential to differentiate dementia due to...

November 8, 2012

HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (“EpiCept”) (NASDAQ OMX Stockholm Exchange and OTCQX: EPCT) today...

November 8, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The...

November 8, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Reports Third Quarter 2012 Results

November 7, 2012

DURHAM, N.C.--(BUSINESS WIRE)--CoLucid Pharmaceuticals, maker of migraine therapy lasmiditan, is attending the BIO-Europe 2012 in Hamburg, Germany

November 7, 2012

SAN FRANCISCO--(BUSINESS WIRE)--The results of a recent study presented yesterday at the American Heart Association Scientific Sessions 2012 conference in Los Angeles showed that a high-quality single-lead ECG can be quickly and easily recorded...

November 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the quarter ended September 30, 2012. During the quarter, Exelixis continued to advance the COMET-1 and COMET-2 phase 3 pivotal...

November 7, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is scheduled to present at the Lazard Capital Markets 9th Annual Healthcare Conference in New York on Wednesday, November 14, 2012 at 9:30 a.m. ET and the Jefferies 2012...

November 7, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the winners of its MiSeq grant program at the American Society of Human Genetics (ASHG) annual meeting in San Francisco. Illumina received almost 850 applications from...

November 7, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the third quarter and nine months ended September 30, 2012. The company also highlighted ADCETRIS (brentuximab vedotin) commercialization...

November 7, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and processes for the production of pharmaceuticals, biofuels and bio-based chemicals, today announced financial results for the third...

November 7, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at Credit Suisse Healthcare Conference

November 7, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the third quarter ended September 30, 2012. “We are looking forward to announcing the results of our Phase 3 trials of tavaborole...

November 7, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced financial and operating results for the third quarter ended September 30, 2012 and other business updates. Total product revenue was $185.1 million for the...

November 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the third quarter ended September 30, 2012.

November 7, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2012 Global Healthcare Conference on Wednesday, November 14, 2012, at 9:20 a.m. GMT (4:20 a.m. EST) in...

November 7, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today reported financial results for the three and nine months ended, September 30, 2012, and provided a business update. Third Quarter Financial Results Net sales for the third...

November 7, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its third quarter ended...

November 7, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ:FLDM) announced it has filed litigation against NanoString Technologies, Inc. for false advertising, unfair competition, and unlawful trade practice in violation of the Lanham Act.

November 7, 2012

BOSTON--(BUSINESS WIRE)--On November 7, 2012, H&Q Healthcare Investors declared a stock distribution of $0.38 per share. The record date for the stock distribution is November 21, 2012 and the payable date is December 31, 2012. The Fund will...

November 7, 2012

NORTHWOOD, Ohio--(BUSINESS WIRE)--NAMSA, the world’s leading medical device research organization, is expanding its laboratories in Lyon, France, due to increased demand for its biocompatibility and histopathology services.

November 7, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Moberg Derma AB (OMX: MOB) today announces that it has received the final results from a phase II study of MOB-015 in patients with onychomycosis. The clinical efficacy was unsatisfactory, and the...

November 7, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced results from a post-hoc analysis of a sub-group of the PLATO study. This new analysis evaluated outcomes in 9,946 patients with non–ST-elevation acute coronary syndrome (...

November 7, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that it will release its third quarter 2012 financial results before the U.S. stock market opens on...

November 7, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference

November 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Though more capable of long-term management, only 31% of pharmaceutical companies report dedicated lifecycle management teams, finds Cutting Edge Information study

November 7, 2012

SANTA CLARA, Calif. & PENZBERG, Germany--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) and Roche (SIX: RO, ROG) (OTCQX: RHHBY) today announced the signing of an exclusive agreement to provide continued service to NimbleGen microarray...

November 7, 2012

AARHUS, Denmark--(BUSINESS WIRE)--Today, CLC bio and the independent software vendor, BioQL, announced the release of the MedQL Variant Prioritizer plug-in for CLC Genomics Workbench. The plugin connects with MedQL’s online database to prioritize...

November 7, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Researchers to Present Additional Data on Soliris® (eculizumab) as a Treatment for Patients with PNH and aHUS at ASH Annual Meeting

November 7, 2012

HOBOKEN, N.J.--(BUSINESS WIRE)--As part of its commitment to support the bleeding disorders community, Octapharma USA will sponsor several educational programs and present five clinical posters at the National Hemophilia Foundation’s (NHF) 64th...

November 7, 2012

WILMINGTON, N.C. & ROCHESTER, N.Y.--(BUSINESS WIRE)--Myo Technologies, LLC provider of Myotonology®, the only U.S. patented, totally non-invasive microcurrent skin toning treatment is currently being used in The Spa at Midtown – Midtown...

November 7, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--On November 14, 2012, at 4:00 p.m. EST, watch a nipple-sparing mastectomy to remove breast tissue from a patient with a family history of breast cancer, from the Baptist Health Breast Center.

November 7, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast:     What: Transgenomic, Inc. Third Quarter 2012 Financial Results and Business Update Conference Call   When: Wednesday, November 7, 2012 @ 5:00...

November 7, 2012

NEW YORK--(BUSINESS WIRE)--Hessen will participate in the MEDICA 2012, November 14-17, 2012 in Düsseldorf. Hessen utilizes the appeal of MEDICA to present the quality of its business location and international medtech industry

November 7, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that Klaus Lindpaintner, MD, MPH, and Edison T. Liu, MD, have joined its Scientific Advisory Board. The board was...